bioRxivGenomicsPreprint
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome
Liguo ZhangiD, Alexsia L. Richards, Andrew S. KhaliliD, Emile Wogram, Haiting Ma, Richard A. YoungiD, Rudolf JaenischiD
Abstract
Prolonged SARS-CoV-2 RNA shedding and recurrence of PCR-positive tests have been widely reported in patients after recovery, yet these patients most commonly are non-infectious1-14. Here we investigated the possibility that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the human genome and that transcription of the integrated sequences might account for PCR-positive tests. In support of this hypothesis, we found chimeric transcripts consisting of viral fused to cellular sequences in published data sets of SARS-CoV-2 infected cultured cells and primary cells of patients, consistent with the transcription of viral sequences integrated into the genome. To experimentally corroborate the possibility of viral retro-integration, we describe evidence that SARS-CoV-2 RNAs can be reverse transcribed in human cells by reverse transcriptase (RT) from LINE-1 elements or by HIV-1 RT, and that these DNA sequences can be integrated into the cell genome and subsequently be transcribed. Human endogenous LINE-1 expression was induced upon SARS-CoV-2 infection or by cytokine exposure in cultured cells, suggesting a molecular mechanism for SARS-CoV-2 retro-integration in patients. This novel feature of SARS-CoV-2 infection may explain why patients can continue to produce viral RNA after recovery and suggests a new aspect of RNA virus replication.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
Abstract summary
Claude Opus 5.5 · xhigh effort · 2 Nov 2026 · from the abstract
SARS-CoV-2 RNA can be reverse-transcribed by LINE-1 or HIV-1 reverse transcriptase, integrated into the human genome, and transcribed as chimeric viral-cellular RNAs.
Recovered SARS-CoV-2 patients frequently exhibit prolonged viral RNA shedding and recurrent polymerase chain reaction (PCR)-positive results despite being non-infectious. Investigating published patient and cultured cell datasets alongside experimental assays indicates that reverse transcription and genomic integration of SARS-CoV-2 sequences may explain persistent viral RNA production after recovery.
Key results
ClaimedPublished datasets from SARS-CoV-2-infected cultured cells and primary patient cells contain chimeric transcripts fusing viral and cellular sequences, consistent with transcription of genomically integrated viral sequences.
Detected viral-cellular chimeric transcripts in published datasets of infected cultured cells and patient primary cells; dataset counts and chimeric transcript frequencies are not stated in the abstract. · Abstract
ClaimedSARS-CoV-2 RNA can be reverse-transcribed in human cells by LINE-1 or HIV-1 reverse transcriptase (RT), integrated into the host genome, and subsequently transcribed.
Experimental assays in human cells with LINE-1 RT or HIV-1 RT; specific cell lines and quantitative integration rates are not reported in the abstract. · Abstract
ClaimedSARS-CoV-2 infection or cytokine exposure induces endogenous human LINE-1 expression in cultured cells, providing a candidate mechanism for viral retro-integration.
Measured endogenous LINE-1 expression in cultured cells following SARS-CoV-2 infection or cytokine treatment; fold-change values are not provided in the abstract. · Abstract
Methods, data and reproducibility
The authors searched published datasets from SARS-CoV-2-infected cultured cells and patient primary cells for chimeric viral-cellular transcripts. They then experimentally tested reverse transcription, genomic integration, and subsequent transcription of SARS-CoV-2 RNA in human cells via LINE-1 or HIV-1 reverse transcriptase, and measured endogenous LINE-1 induction after viral infection or cytokine exposure.
- Published datasets of SARS-CoV-2-infected cultured cells and primary cells from patients · human, SARS-CoV-2
- Cultured human cells experimentally tested for LINE-1/HIV-1 reverse transcription, genomic integration, and cytokine/infection-induced LINE-1 expression · human, SARS-CoV-2
- Reproducibility gaps
- Published datasets are referenced without accessions or URLs in the abstract.
Limitations (2)
- Experimental validation of reverse transcription, genomic integration, and LINE-1 induction was performed in cultured cells rather than directly demonstrating integration in patients in vivo. · noted in this summary
- Abstract only; quantitative chimeric transcript counts, integration frequencies, cell types, and dataset accessions are not reported. · noted in this summary
Read this if you study SARS-CoV-2 host-virus interactions, endogenous retroelements such as LINE-1, or mechanisms underlying prolonged viral RNA detection after recovery.
- Citations
- 70
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2-host chimeric RNA-sequencing reads do not necessarily signify virus integration into the host DNA
A. Kazachenka, G. Kassiotis·bioRxiv·Mar 5, 2021
- LINE1-mediated reverse transcription and genomic integration of SARS-CoV-2 mRNA detected in virus-infected but not in viral mRNA-transfected cells
Liguo Zhang, Punam Bisht, … Rudolf Jaenisch·VirusesPeer-reviewed·Feb 25, 2023
- Comprehensive analysis of RNA-seq and whole genome sequencing data reveals no evidence for SARS-CoV-2 integrating into host genome
Yusheng Chen, Shuaiyao Lu, … Yun‐Gui Yang·Protein & CellPeer-reviewed·Aug 2, 2021
- No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing
Nathan Smits, Jay Rasmussen, … Geoffrey J. Faulkner·Cell ReportsPeer-reviewed·Jul 28, 2021
- Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual
B. Yan, S. Chakravorty, … M. Kazemian·Journal of VirologyPeer-reviewed·Jul 12, 2021
- Putative host-derived insertions in the genome of circulating SARS-CoV-2 variants
Yi‐Yan Yang, Keith Dufault‐Thompson, … Xiaofang Jiang·mSystemsPeer-reviewed·May 18, 2022